171 related articles for article (PubMed ID: 38367169)
21. Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation.
Schmidt M; Johansen MB; Robertson DJ; Maeng M; Kaltoft A; Jensen LO; Tilsted HH; Bøtker HE; Sørensen HT; Baron JA
Aliment Pharmacol Ther; 2012 Jan; 35(1):165-74. PubMed ID: 22050009
[TBL] [Abstract][Full Text] [Related]
22. Association of Proton Pump Inhibitor Use With All-Cause and Cause-Specific Mortality.
Lo CH; Ni P; Yan Y; Ma W; Joshi AD; Nguyen LH; Mehta RS; Lochhead P; Song M; Curhan GC; Cao Y; Chan AT
Gastroenterology; 2022 Oct; 163(4):852-861.e2. PubMed ID: 35788344
[TBL] [Abstract][Full Text] [Related]
23. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
[TBL] [Abstract][Full Text] [Related]
24. Cumulative Use of Proton Pump Inhibitors and Risk of Dementia: The Atherosclerosis Risk in Communities Study.
Northuis CA; Bell EJ; Lutsey PL; George KM; Gottesman RF; Mosley TH; Whitsel EA; Lakshminarayan K
Neurology; 2023 Oct; 101(18):e1771-e1778. PubMed ID: 37558503
[TBL] [Abstract][Full Text] [Related]
25. Impact of Proton Pump Inhibitor Use on the Comparative Effectiveness and Safety of Prasugrel Versus Clopidogrel: Insights From the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) Study.
Jackson LR; Peterson ED; McCoy LA; Ju C; Zettler M; Baker BA; Messenger JC; Faries DE; Effron MB; Cohen DJ; Wang TY
J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792656
[TBL] [Abstract][Full Text] [Related]
26. Proton Pump Inhibitor Usage and the Risk of Mortality in Hemodialysis Patients.
de Francisco ALM; Varas J; Ramos R; Merello JI; Canaud B; Stuard S; Pascual J; Aljama P;
Kidney Int Rep; 2018 Mar; 3(2):374-384. PubMed ID: 29725641
[TBL] [Abstract][Full Text] [Related]
27. Proton pump inhibitor usage is associated with higher all-cause mortality and CV events in peritoneal dialysis patients.
Zeng Y; Liu L; Zhu L; Zhan X; Peng F; Feng X; Zhou Q; Zhang Y; Wang Z; Liang J; Li J; Wen Y
Ren Fail; 2022 Dec; 44(1):407-414. PubMed ID: 35236240
[TBL] [Abstract][Full Text] [Related]
28. Real-World Relationship Between Proton Pump Inhibitors and Cerebro-Cardiovascular Outcomes Independent of Clopidogrel.
Li S; Liu F; Chen C; Zhu W; Ma J; Hu J; Xu J; Hong K
Int Heart J; 2019 Jul; 60(4):910-918. PubMed ID: 31308328
[TBL] [Abstract][Full Text] [Related]
29. Proton-pump Inhibitor Use and Myocardial Infarction: A Nested Case-Control Study in the UK Clinical Practice Research Datalink.
Qian Y; Jick S
Epidemiology; 2020 May; 31(3):423-431. PubMed ID: 31809341
[TBL] [Abstract][Full Text] [Related]
30. Proton pump inhibitor use and hearing loss in patients with type 2 diabetes: Evidence from a hospital-based case-control study and a population-based cohort study.
Yee J; Han HW; Gwak HS
Br J Clin Pharmacol; 2022 Jun; 88(6):2738-2746. PubMed ID: 34970788
[TBL] [Abstract][Full Text] [Related]
31. Lack of Association Between Proton Pump Inhibitor Use and Cognitive Decline.
Wod M; Hallas J; Andersen K; García Rodríguez LA; Christensen K; Gaist D
Clin Gastroenterol Hepatol; 2018 May; 16(5):681-689. PubMed ID: 29391266
[TBL] [Abstract][Full Text] [Related]
32. Association Between Proton Pump Inhibitor Use and Risk of Fracture in Children.
Wang YH; Wintzell V; Ludvigsson JF; Svanström H; Pasternak B
JAMA Pediatr; 2020 Jun; 174(6):543-551. PubMed ID: 32176276
[TBL] [Abstract][Full Text] [Related]
33. Use of proton pump inhibitors is associated with an increase in adverse cardiovascular events in patients with hemodialysis: Insight from the kids registry.
Kosedo I; Tokushige A; Takumi T; Yoshikawa A; Teraguchi K; Takenouchi K; Shiraishi K; Ikeda D; Imamura M; Sonoda T; Kanda D; Ikeda Y; Ido A; Ohishi M
Eur J Intern Med; 2020 Feb; 72():79-87. PubMed ID: 31735546
[TBL] [Abstract][Full Text] [Related]
34. Intermittent concurrent use of clopidogrel and proton pump inhibitors did not increase risk of adverse clinical outcomes in Chinese patients with coronary artery disease.
He W; Shu X; Zhu E; Deng B; Lin Y; Wu X; Zhou Z; Wang J; Nie R
BMC Cardiovasc Disord; 2021 Feb; 21(1):75. PubMed ID: 33546595
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of concomitant use of proton pump inhibitors with aspirin-clopidogrel dual antiplatelet therapy in coronary heart disease: A systematic review and meta-analysis.
Luo X; Hou M; He S; Yang X; Zhang P; Zhao Y; Xing H
Front Pharmacol; 2022; 13():1021584. PubMed ID: 36703730
[No Abstract] [Full Text] [Related]
36. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
[TBL] [Abstract][Full Text] [Related]
37. No increased risk of cardiovascular events in older adults initiating dipeptidyl peptidase-4 inhibitors vs therapeutic alternatives.
Gokhale M; Buse JB; Jonsson Funk M; Lund J; Pate V; Simpson RJ; Stürmer T
Diabetes Obes Metab; 2017 Jul; 19(7):970-978. PubMed ID: 28195389
[TBL] [Abstract][Full Text] [Related]
38. Adverse outcomes of proton pump inhibitors in patients with chronic kidney disease: The CKD-REIN cohort study.
Liabeuf S; Lambert O; Metzger M; Hamroun A; Laville M; Laville SM; Frimat L; Pecoits-Filho R; Fouque D; Massy ZA; Jacquelinet C; Stengel B;
Br J Clin Pharmacol; 2021 Jul; 87(7):2967-2976. PubMed ID: 33368448
[TBL] [Abstract][Full Text] [Related]
39. Impact of Concomitant Use of Proton Pump Inhibitors and Clopidogrel on Recurrent Stroke and Myocardial Infarction.
Lee YK; Lim HS; Choi YI; Choe EJ; Kim S; You SC; Lee KJ; Kim Y; Park DH; Shin WG; Seo SI
Pharmaceuticals (Basel); 2023 Aug; 16(9):. PubMed ID: 37765021
[TBL] [Abstract][Full Text] [Related]
40. Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans.
Xie Y; Bowe B; Li T; Xian H; Yan Y; Al-Aly Z
BMJ Open; 2017 Jul; 7(6):e015735. PubMed ID: 28676480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
